|
1
|
Coussa RG and Traboulsi EI: Choroideremia:
A review of general findings and pathogenesis. Ophthalmic Genet.
33:57–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rudolph G, Preising M, Kalpadakis P,
Haritoglou C, Lang GE and Lorenz B: Phenotypic variability in three
carriers from a family with choroideremia and a frameshift mutation
1388delCCinsG in the REP-1 gene. Ophthalmic Genet. 24:203–214.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Renner AB, Kellner U, Cropp E, Preising
MN, MacDonald IM, van den Hurk JA, Cremers FP and Foerster MH:
Choroideremia: Variability of clinical and electrophysiological
characteristics and first report of a negative electroretinogram.
Ophthalmology. 113:e1–e10. 2006. View Article : Google Scholar
|
|
4
|
van den Hurk JA, van de Pol DJ, Wissinger
B, van Driel MA, Hoefsloot LH, de Wijs IJ, van den Born LI,
Heckenlively JR, Brunner HG, Zrenner E, et al: Novel types of
mutation in the choroideremia (CHM) gene: A full-length L1
insertion and an intronic mutation activating a cryptic exon. Hum
Genet. 113:268–275. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Radziwon A, Arno G, Wheaton K D, McDonagh
EM, Baple EL, Webb-Jones K, Birch G D, Webster AR and MacDonald IM:
Single-base substitutions in the CHM promoter as a cause of
choroideremia. Hum Mutat. 38:704–715. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Edwards TL, Williams J, Patrício MI,
Simunovic MP, Shanks M, Clouston P and MacLaren RE: Novel
non-contiguous exon duplication in choroideremia. Clin Genet.
93:144–148. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leung KF, Baron R and Seabra MC: Thematic
review series: Lipid posttranslational modifications.
geranylgeranylation of Rab GTPases. J Lipid Res. 47:467–475. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ali BR and Seabra MC: Targeting of Rab
GTPases to cellular membranes. Biochem Soc Trans. 33:652–656. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Larijani B, Hume AN, Tarafder AK and
Seabra MC: Multiple factors contribute to inefficient prenylation
of Rab27a in Rab prenylation diseases. J Biol Chem.
278:46798–46804. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Futter CE, Ramalho JS, Jaissle GB,
Seeliger MW and Seabra MC: The role of Rab27a in the regulation of
melanosome distribution within retinal pigment epithelial cells.
Mol Biol Cell. 15:2264–2275. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seabra MC, Ho YK and Anant JS: Deficient
geranylgeranylation of Ram/Rab27 in choroideremia. J Biol Chem.
270:24420–24427. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tolmachova T, Anders R, Abrink M, Bugeon
L, Dallman MJ, Futter CE, Ramalho JS, Tonagel F, Tanimoto N,
Seeliger MW, et al: Independent degeneration of photoreceptors and
retinal pigment epithelium in conditional knockout mouse models of
choroideremia. J Clin Invest. 116:386–394. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tolmachova T, Wavre-Shapton ST, Barnard
AR, MacLaren RE, Futter CE and Seabra MC: Retinal pigment
epithelium defects accelerate photoreceptor degeneration in cell
type-specific knockout mouse models of choroideremia. Invest
Ophthalmol Vis Sci. 51:4913–4920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Allen RC, Zoghbi HY, Moseley AB,
Rosenblatt HM and Belmont JW: Methylation of HpaII and HhaI sites
near the polymorphic CAG repeat in the human androgen-receptor gene
correlates with X chromosome inactivation. Am J Hum Genet.
51:1229–1239. 1992.PubMed/NCBI
|
|
15
|
Beever C, Lai BP, Baldry SE, Peñaherrera
MS, Jiang R, Robinson WP and Brown CJ: Methylation of ZNF261 as an
assay for determining X chromosome inactivation patterns. Am J Med
Genet A. 120A:439–441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Guan L, Fang S, Jiang H, Xiao X,
Yang J, Wang P, Yin Y, Guo X, Wang J, et al: Exome sequencing
reveals CHM mutations in six families with atypical choroideremia
initially diagnosed as retinitis pigmentosa. Int J Mol Med.
34:573–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Renner AB, Fiebig BS, Cropp E, Weber BH
and Kellner U: Progression of retinal pigment epithelial
alterations during long-term follow-up in female carriers of
choroideremia and report of a novel CHM mutation. Arch Ophthalmol.
127:907–912. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Q, Liu L, Xu F, Li H, Sergeev Y, Dong
F, Jiang R, MacDonald I and Sui R: Genetic and phenotypic
characteristics of three Mainland Chinese families with
choroideremia. Mol Vis. 18:309–316. 2012.PubMed/NCBI
|
|
19
|
Perez-Cano HJ, Garnica-Hayashi RE and
Zenteno JC: CHM gene molecular analysis and X-chromosome
inactivation pattern determination in two families with
choroideremia. Am J Med Genet A. 149A:2134–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Esposito G, De Falco F, Tinto N, Testa F,
Vitagliano L, Tandurella IC, Iannone L, Rossi S, Rinaldi E,
Simonelli F, et al: Comprehensive mutation analysis (20 families)
of the choroideremia gene reveals a missense variant that prevents
the binding of REP1 with Rab geranylgeranyl transferase. Hum Mutat.
32:1460–1469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baron RA and Seabra MC: Rab
geranylgeranylation occurs preferentially via the pre-formed
REP-RGGT complex and is regulated by geranylgeranyl pyrophosphate.
Biochem J. 415:67–75. 2008. View Article : Google Scholar : PubMed/NCBI
|
